Clinical pseudomonas aeruginosa: Potential factors of pathogenicity and resistance to antimicrobials

Folia Microbiologica

Volumn 51, Issue 6, 2006, Pages 633-638

  Hostacka A ^a   Ciznar I ^a   Slobodnikova L ^b   Kotulova D ^b  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CRYSTAL VIOLET; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; HYDROGEN PEROXIDE; OXIDIZING AGENT;

ADAPTATION; ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; BIOSYNTHESIS; DRUG EFFECT; GRAM NEGATIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; HUMAN; HYDROPHOBICITY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOVEMENT (PHYSIOLOGY); OXIDATIVE STRESS; PATHOGENICITY; PHENOTYPE; PSEUDOMONAS AERUGINOSA; VIRULENCE;

4-BUTYROLACTONE; ADAPTATION, PHYSIOLOGICAL; ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; GENTIAN VIOLET; HUMANS; HYDROGEN PEROXIDE; HYDROPHOBICITY; MOVEMENT; OXIDANTS; OXIDATIVE STRESS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE;

PSEUDOMONAS AERUGINOSA;

EID: 33847174708     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931631     Document Type: Article

References (39)

1. ALLISON D.G., MC BAIN A.J., GILBERT P.: Microbial biofilms; problems of control, pp. 309-327 in D.G. Allison, P. Gilbert, H. Lappin-Scott, M. Wilson (Eds): Community, Structure and Cooperation in Biofilms, Cambridge University Press, Cambridge 2000.
2. BONAFONTE M.A., SOLANO K., SESMA B., ALVAREZ M., MONTUENOA L., GARCIA-ROS D., GAMAZO C.: The relationship between glycogen synthesis, biofilm formation and virulence in Salmonella enteritidis. FEMS Microbiol.Lett. 191, 31-36 (2000).
3. BONFIGLIO G., MARCHETTI F.: In vitro activity of ceftazidime, cefepime and imipenem on 1005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to β-lactams. Chemotherapy 46, 229-234 (2000).
4. BRAGA P.C., DALSASSO M.: Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence. J.Antimicrob.Chemother. 45, 15-25 (2000).
5. CAMPRUBÍ S., MERINO S., BENEDÍ J., WILLIAMS P., TOMÁS M.: Physicochemical surface properties of Klebsiella pneumoniae. Curr. Microbiol. 24, 31-33 (1992).
6. CAVALLO J.D., LEBLANC F., FABRE R., GERP B.: Pseudomonas aeruginosa: susceptibility to antibiotics and distribution of β-lactam resistance mechanisms. Pathol.Biol. 48, 472-477 (2000).
7. ĆERNOHORSKÁ L., VOTAVA M.: Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria. Folia Microbiol. 49, 75-78 (2004).
8. DAVIES D.G., PARSEK M.R., PEARSON J.P., IGLEWSKI B.A., COSTERTON J.W., GREENBERG E.P.: The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280, 295-298 (1998).
9. EDGEWORTH J.D., TREACHER D.F., EYKYN S.J.: A 25-year study of nosocomial bacteremia in adult intensive care unit. Crit.Care Med. 27, 1421-1428 (1999).
10. FLUIT A.C., VERHOEF J., SCHMITZ F.J., The European Sentry Participants: Antimicrobial resistance in European isolates of Pseudomonas aeruginosa. Eur.J.Clin.Microbiol.Infect.Dis. 19, 370-374 (2000).
11. FUQUA C., WINANS S., GREENBERG E.P.: Census and consensus in bacterial ecosystems: the Lux R-Lux I family of quorum sensing transcriptional regulators. Ann.RevMcrobiol. 50, 727-751 (1996).
12. 1 integrins and fibronectin are involved in adherence of the Pseudomonas aeruginosa ER97314 clinical strain to A549 cells. Folia Microbiol. 49, 757-762 (2004).
13. GAL Z., SZABÓ D., KOVÁCS P., HERNADI F., TÓTH-MARTINEZ B., ROZGONYI F.: β-Lactam susceptibility patterns and investigation of cephalosporin hydrolysing β-lactamases of Gram-negative extraintestinal clinical isolates. Internat.J.Antimicrob.Agents 16, 395-400 (2000).
14. GATTRINGER R., NIKS M., OSTERTAG R., SCHWARZ K., MEDVEDOVIC H., GRANINGER W., GEORGOPOULOS A.: Evaluation of MidiTech automated colorimetric MIC reading for antimicrobial susceptibility testing. J.Antimicrob.Chemother. 49, 651-659 (2002).
15. HARJAI K., KHANDWAHA R.K., MITTAL R., YADAV V., GUPTA V., SHARMA S.: Effect of pH on production of virulence factors by biofilm cells of Pseudomonas aeruginosa. Folia Microbiol. 50, 99-102 (2005).
16. HASSETT D.J., SCHWEIZER H.P., OHMAN D.E.: Pseudomonas aeruginosa sodA and sodB mutants defective in manganese- and ironcofactored Superoxide dismutase activity demonstrate the importance of the iron-cofactored form in aerobic metabolism. J.Bacteriol. 177, 6330-6337 (1995).
17. HØIBY N.: Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis. Paediatr.Drugs 2, 451-463 (2000).
18. KADRY A.A.: Lack of efflux mechanism in a clinical isolate of Pseudomonas aerugtnosa highly resistant to β-lactams and imipenem. Folia Microbiol. 48, 529-533 (2003).
19. KARAKOÇ B, GERÇEKER A.A.: In vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa. Internat.J.Antimicrob.Agents 18, 567-570 (2001).
20. KÖHLER T., VAN DELDEN C., KOCJANCIC CURTY L., HAMZEHPOUR M.M., PECHERE J.C.: Overexpression of the Mex EF-Opr N multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J.Bacteriol. 183, 5213-5222 (2001).
21. LIU P.V., ABE Y., BATES J.L.: The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. J.Infect.Dls. 108, 218-228 (1961).
22. MAJTÁN V., HOŠIACKÁ A., MAJTÁNOVÁ L'., TRUPL J.: Toxinogenicity and markers of pathogenicity of Pseudomonas aeruginosa strains isolated from patients with tumor diseases. Folia Microbiol. 47, 445-449 (2002).
23. MATHAI D., LEWIS M.T., KUGLER K.C., PFALLER M.A., JONES R.N., The Sentry Participants Group (North America): Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia -1. Results from the Sentry Antimicrobial Surveillance Program (North America 1998). Diagn.Microbiol.Infect.Dis. 39, 105-116 (2001).
24. OKAZAKI M., ONOGAWA T., ARAKI K., EGAMI T., FURUYA N., ENDO N., UCHIMURA H.: Isolation frequency and biological characteristics of the multiple-antibiotic resistant Pseudomonas aeruginosa isolated from clinical specimens. Kansen-shogaku Zasshi 71, 1181-1186 (1997).
25. O'TOOLE G.A., KOLTER R.: Initiation of biofilm formation in Pseudomonas fluorescens WCS 365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol.Microbiol. 28, 449-461 (1998a).
26. O'TOOLE G.A., KOLTER R.: Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol. 30, 295-304 (19986).
27. PARASKAKI I., LEBESSI E., LEOAKIS N.J.: Epidemiology of community-acquired Pseudomonas aeruginosa infections in children. Eur. J.Clin.Microbiol.Infect.Dis. 15, 782-786 (1996).
28. PESCI E.G., IQLEWSKI B.H.: Quorum sensing, pp. 55-65 in D.L. Burns, J.T. Barbieri, B.H. Iglewski, R. Rappouli (Eds): Bacterial Protein Toxins. ASM Press, Washington (DC) 2003.
29. PUZOVÁ H., SIEGFRIED L., KMEŤ OVÁ M., ĎUROVIČOVÁ J., KERESTEŠOVÁ A.: Characteristics of Pseudomonas aerigunosa strains isolated from urinary tract infections. Folia Microbiol. 39, 337-341 (1994).
30. RAVN L., CHRISTENSEN A.B., MOLIN S., GIVSKOV M., GRAM L.: Methods for detecting acylated homoserine lactones produced by Gram-negative bacteria and their application in studies of AHL-production kinetics. J.Microbiol.Meth. 44, 239-251 (2001).
31. ROSENBERG M., GUTNICK D., ROSENBERG E.: Adherence of bacteria to hydrocarbons: a simple method for measuring cell-surface hydrophobicity. FEMS Microbiol.Lett. 9, 29-33 (1980).
32. SEIB K.L., TSENG H.J., Me EWAN G., APICELLA M.A., JENNINGS M.P.: Defenses against oxidative stress in Neisseria gonorrhoeas and Neisseria meningitidis: distinctive systems for different lifestyles. J.Infect.Dis. 190, 136-147 (2004).
33. SINGH P.K., SCHAEFER A.L., PARSEK M.R., MONINGER T.O., WELSH M.J., GREENBERG E.P.: Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762-764 (2000).
34. STRUELENS M.J., DENIS O., RODRIQUEZ-VILLALOBOS H.: Microbiology of nosocomial infections: progress and challenges. Microb. Infect. 6, 1043-1048 (2004).
35. VAN DELDEN C., IGLEWSKI B.H.: Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg.Infect.Dis. 4, 551-560 (1998).
36. VAN HOUDT R., AERSTEN A., JANSEN A., QUINTANA A.L., MICHIELS C.W.: Biofilm formation and cell-to-cell signaling in Gram-negative bacteria isolated from a food processing environment. J.Appl.Microbiol. 96, 177-184 (2004).
37. WOODS D.E., SOKOL P.A., BRYAN L.E., STOREY D.G., MATTINGLY M.J., VOGEL H.J., CERI H.: In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement. J.Infect.Dis. 163, 143-149 (1991).
38. YADAV V., HARJAI K., KAUR R., JOSHI K., SHARMA S.: Urovirulence of Pseudomonas aeruginosa: planktonic cells vs. biofilm cells. Folia Microbiol. 49, 465-471 (2004).
39. ŽATKOVIČ B., TRUPL J., MAJTÁN V.: Survey of susceptibility to selected antibiotics of Pseudomonas aeruginosa strains isolated from patients with tumor disease and their relationship to serotype. Folia Microbiol. 38, 415-420 (1993).